The move by Health Canada keeps thousands of medical marijuana users off balance as to how long they can continue home growing under personal production licences.
They had been under a federal directive to stop growing, destroy any unused pot and confirm in writing by April 30 they had done so or face potential police enforcement.
Users behind a constitutional challenge of the new medical marijuana rules fear higher prices and lower quality pot under the new system of regulated commercial producers.
It’s unclear how quickly an appeal of the injunction will be heard, but the broader case is expected to go to trial sometime this year.
Health Minister Rona Ambrose said Monday she is working with organizations of health professionals to address their concerns about the lack of dosage guidelines and appropriate health cautions for medical marijuana use.
“They want clearer guidance on safety and effectiveness and want aut. . . . . READ MORE
Millions of ordinary Americans are now able to walk into a marijuana dispensary and purchase bags of pot on the spot for a variety of medical ailments. But if you’re a researcher like Sue Sisley, a psychiatrist who studies post traumatic stress disorder, getting access to the drug isn’t nearly so easy.
That’s because the federal government has a virtual monopoly on growing and cultivating marijuana for scientific research, and getting access to the drug requires three separate levels of approval.
Marijuana offers hope for 6-year-old girl with rare condition: In marijuana, Lydia Schaeffer’s family members think they might have found a treatment that works. Now, they are trying to help legalize the drug.
Sisley’s fight to get samples for her study — now in its fourth month — illuminates the complex politics of marijuana in the United States.
While 20 states and the District have made medical marijuana legal — in Colorado and Washington state the drug is also legal for recreational use — it remains among the most tightly contr. . . . . READ MORE
On Friday morning, the judge granted an injunction allowing those who have a personal production licence to grow medical marijuana to continue for now, pending the outcome of a trial to be held at a later date.
Those with an authorization to possess medical marijuana will also be allowed to continue to do so under the injunction, though they will only be permitted to hold up to 150 grams.
Without the injunction, Health Canada’s new laws, which go into effect April 1, would end the home production of medical marijuana.
Instead, all those using medical marijuana would have to purchase it from large-scale commercial facilities that are being set up around the country.
Patients have voiced concern about the cost and the quality of the product they will be able to obtain under the new system.
Abbotsford, B.C., lawyer John Conroy was in court this week seeking the interim injunction for growers.
Conroy alleges that Health Canada’s pronouncements are . . . . . READ MORE
There should be, one might think, a note of triumph or at least quiet satisfaction in Muraco Kyashna-tocha’s voice. Her patient-based cooperative in north Seattle dispenses medical marijuana to treat seizures, sleeplessness and other maladies. And with the state gearing up to open its first stores selling legal marijuana for recreational use, the drug she has cultivated, provided to patients and used herself for years seems to be barreling toward the mainstream.
But her one-word summary of the outlook for medical marijuana is anything but sunny: “Disastrous,” she said, standing in her shop, Green Buddha, which she fears she will soon have to close.
The legalization of recreational marijuana for adults in Washington, approved by voters in 2012 and now being phased in, is proving an unexpectedly anxious time for the users, growers and dispensers of medical marijuana, who came before and in many ways blazed the trail for marijuana’s broader acceptance.
In the 16 years since medical marijuana became legal here, an entire ecosystem of neighborhood businesses and cooperative gardens took root, with employees who could direct med. . . . . READ MORE
A scientist in the United Kingdom has found that compounds derived from marijuana can kill cancerous cells found in people with leukemia, a form of cancer that is expected to cause an estimated 24,000 deaths in the United States this year.
“Cannabinoids have a complex action; it hits a number of important processes that cancers need to survive,” study author Dr. Wai Liu, an oncologist at the University of London’s St. George medical school, told The Huffington Post. “For that reason, it has really good potential over other drugs that only have one function. I am impressed by its activity profile, and feel it has a great future, especially if used with standard chemotherapies.”
Liu’s study was recently published in the journal Anticancer Research. It was supported by funding from GW Pharmaceuticals, which already makes a cannabis-derived drug used to treat spasticity caused by multiple sclerosis.
The study looked at the effects of six different non-psychoactive cannabinoids — compounds derived from marijuana that do not. . . . . READ MORE
Under the law that went into effect Wednesday, PTSD joins cancer, glaucoma, hepatitis C and others on the list of conditions patients must have to qualify for medical marijuana use in Maine.
Hundreds of Maine veterans already use marijuana to treat PTSD, but they weren’t previously able to get it from their doctors, said Paul McCarrier, legislative liaison for the Medical Marijuana Caregivers of Maine.
“This unties the hands of doctors to allow them to treat their patients,” he said.
Retired Marine Corps Sgt. Ryan Begin is one of those veterans already using the drug. Begin lost 4 inches of his right arm, including his elbow, from an IED explosion during his second tour in Iraq in 2004. He started using medical marijuana to deal with the pain, but it has also helped manage his PTSD, which caused flashbacks . . . . . READ MORE
Marijuana was Canada’s newest mail-order product Tuesday, the inaugural day of a controlled medical marijuana industry that is expected to grow to more than $1 billion dollars within 10 years. But even as the new system privatizes distribution, critics fear regulation under the conservative-led government will make it harder for patients to get access to the drug.
In Canada, medical marijuana has been legal but highly regulated for more than a decade. Patients with doctor approval could grow or have someone else grow small quantities or request limited amounts from Health Canada, the national healthcare department.
But the conservative-led government voted earlier this year to effectively scrap that system in favor of a private—but also strictly regulated—system, targeting the flow of legal marijuana into the black market and shedding Health Canada’s role in marijuana production. Health Canada will phase out the current system, under which it sells registered users marijuana grown by Prairie Plant Systems, by the end of March.
Instead, starting Tuesday, medical marijuana users, or aspiring users, can send in an app. . . . . READ MORE
Connecticut’s new medical marijuana program will move forward now that regulations governing the system were approved by a key legislative committee in a voice vote Tuesday afternoon.
The vote, by the regulations review committee, clears the way for the state to seek applications for marijuana growers and sellers. William Rubenstein, consumer protection commissioner, said he expects that producers and dispensaries will be up and running by spring or early summer next year.
To qualify to use marijuana for medical purposes, a patient must be diagnosed with one of the following debilitating medical conditions: cancer, glaucoma, HIV, AIDS, Parkinson’s disease, multiple sclerosis, damage to the nervous tissue of the spinal cord with objective neurological indication of intractable spasticity, epilepsy, cachexia, wasting syndrome, Crohn’s disease or post-traumatic stress disorder. The Department of Consumer Protection can add other medical conditions to the list, in consultation with a state-appointed, eight-member board of physicians.
The patient would receive certification from a physician and register with consumer protectio. . . . . READ MORE
A little over a week ago, Dr. Sanjay Gupta aired a one hour CNN special on medical marijuana. The impact of his special and an op-ed that he wrote for CNN – where he apologized for his past opposition to medical marijuana – has been incredible!
In the run-up to Gupta’s CNN special, his op-ed made national news and was shared more than half a million times on Facebook. Just a few years ago, he came out against medical marijuana. Yet in his op-ed he expressed regret for not studying the issue more closely and for believing the government’s propaganda.
Dr. Gupta’s show also played a critical role in improving New Jersey’s medical marijuana law. A major focus of the special is a young girl who needs medical marijuana to relieve her constant, debilitating seizures. Coincidently, there is legislation under consideration in New Jersey to expand its medical marijuana law so that minors can access it. The issue was sympathetically covered by Gupta, and within days, New Jersey Governor Chris Christie was being asked about the legislation. Just a few days later Christie committed to signing it.
The latest manifestation of Gupta’. . . . . READ MORE
Christie signaled that he would sign the bill if the Legislature changed it to stipulate that edible forms of marijuana would be available only to qualified minors, and that a pediatrician and psychiatrist had to approve a child’s prescription.
“Today, I am making common sense recommendations to this legislation to ensure sick children receive the treatment their parents prefer, while maintaining appropriate safeguards,” Christie said in a statement.
Christie agreed to allow sick children access to forms of pot that can be eaten. The move is supported by parents worried that the dry-leaf and lozenge forms of the drug pose health concerns.
He also supported removing a limit on the number of marijuana strains that state dispensaries can provide. That would give patients, adults and children, a variety of marijuana strains to choose from; advocates say different strains carry different medicinal properties.
Chri. . . . . READ MORE